Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pro-Bono 2 Vitamin D sub-study in HIV-infected patients
2010-023122-21Phase 4Completed
- Sponsor
- King's College London
- Start
- Oct 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of cholecalciferol in human immunodeficiency virus infection (HIV) and Vitamin D deficiency (VDD), sponsored by King's College London. Primary endpoint: T-regulatory cell numbers at 12 weeks. Started Oct 2011; status: completed.
02
Drugs
cholecalciferol
03
Conditions
human immunodeficiency virus infection (HIV)Vitamin D deficiency (VDD)
Beyond the preview
Go deeper on 2010-023122-21.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-023122-21.